Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 2
2000 1
2001 1
2002 2
2003 3
2004 2
2005 1
2006 4
2007 2
2008 1
2011 1
2012 1
2013 2
2014 2
2016 1
2019 1
2020 1
2021 6
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Fexofenadine.
[No authors listed] [No authors listed] 2021 Sep 20. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Sep 20. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 29999736 Free Books & Documents. Review.
Because of its lack of sedation and low milk levels, maternal use of fexofenadine would not be expected to cause any adverse effects in breastfed infants. Fexofenadine might have a negative effect on lactation, especially in combination with a sympathomimetic agent …
Because of its lack of sedation and low milk levels, maternal use of fexofenadine would not be expected to cause any adverse effects …
OTC drugs for seasonal allergies.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Apr 22;61(1570):57-60. Med Lett Drugs Ther. 2019. PMID: 31169808 No abstract available.
Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis.
Mansfield LE. Mansfield LE. Expert Opin Pharmacother. 2006 May;7(7):941-51. doi: 10.1517/14656566.7.7.941. Expert Opin Pharmacother. 2006. PMID: 16634716 Review.
Newer-generation antihistamines are commonly used to treat allergic rhinitis; however, in patients with severe congestion, a combination of a newer-generation antihistamine and a decongestant is particularly beneficial. A new once-daily fexofenadine/pseudoephedrine
Newer-generation antihistamines are commonly used to treat allergic rhinitis; however, in patients with severe congestion, a combination of …
Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM. Moinuddin R, et al. Ann Allergy Asthma Immunol. 2004 Jan;92(1):73-9. doi: 10.1016/S1081-1206(10)61713-9. Ann Allergy Asthma Immunol. 2004. PMID: 14756468 Clinical Trial.
When the change from baseline was analyzed, there were no statistically significant differences in total symptoms between fexofenadine-pseudoephedrine and loratadine-montelukast (median, -28.5 vs -22.5; P = .33). ...The lack of improvement in sleep in the fexofen
When the change from baseline was analyzed, there were no statistically significant differences in total symptoms between fexofenadine
The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
Sussman GL, Mason J, Compton D, Stewart J, Ricard N. Sussman GL, et al. J Allergy Clin Immunol. 1999 Jul;104(1):100-6. doi: 10.1016/s0091-6749(99)70120-x. J Allergy Clin Immunol. 1999. PMID: 10400846 Clinical Trial.
OBJECTIVE: We sought to compare the efficacy and safety of a fexofenadine HCl/pseudoephedrine HCl combination with that of each individual component in the treatment of ragweed allergy. METHODS: In this Canadian multicenter, double-blind, parallel-group study, 651 p …
OBJECTIVE: We sought to compare the efficacy and safety of a fexofenadine HCl/pseudoephedrine HCl combination with that of eac …
Simultaneous quantification of fexofenadine and pseudoephedrine in human plasma by liquid chromatography/tandem mass spectrometry with electrospray ionization: method development, validation and application to a clinical study.
Nirogi RV, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Komarneni P. Nirogi RV, et al. Rapid Commun Mass Spectrom. 2006;20(20):3030-8. doi: 10.1002/rcm.2701. Rapid Commun Mass Spectrom. 2006. PMID: 16969767
To support the pharmacokinetic and bioavailability study of a once-daily fexofenadine/pseudoephedrine combination, a high-performance liquid chromatography/positive ion electrospray tandem mass spectrometry (HPLC/ESI-MS/MS) method for the simultaneous quantification …
To support the pharmacokinetic and bioavailability study of a once-daily fexofenadine/pseudoephedrine combination, a high-perf …
Alternative and improved method for the simultaneous determination of fexofenadine and pseudoephedrine in their combined tablet formulation.
Maggio RM, Castellano PM, Vignaduzzo SE, Kaufman TS. Maggio RM, et al. J Pharm Biomed Anal. 2007 Dec 21;45(5):804-10. doi: 10.1016/j.jpba.2007.07.024. Epub 2007 Jul 27. J Pharm Biomed Anal. 2007. PMID: 17766076
An alternative method for the determination of fexofenadine (FEX) and pseudoephedrine (PSE) in their combined tablet formulation has been developed, employing the partial least squares (PLS) analysis of spectral data of the analytes in their pharmaceutical associati …
An alternative method for the determination of fexofenadine (FEX) and pseudoephedrine (PSE) in their combined tablet formulati …
Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults.
Howard DR, Haribhakti R, Kittner B, Agrawala P. Howard DR, et al. Curr Med Res Opin. 2005 May;21(5):769-76. doi: 10.1185/030079905x43703. Curr Med Res Opin. 2005. PMID: 15969876 Clinical Trial.
OBJECTIVE: A 24-h extended-release formulation of fexofenadine HCl 180 mg/pseudoephedrine HCl 240 mg (FEX 180 mg/PSE 240 mg) has recently been approved by the US Food and Drug Administration for symptom relief of seasonal allergic rhinitis, including nasal congestio …
OBJECTIVE: A 24-h extended-release formulation of fexofenadine HCl 180 mg/pseudoephedrine HCl 240 mg (FEX 180 mg/PSE 240 mg) h …
Effect of fexofenadine/pseudoephedrine combination tablet on nasal obstruction in patients with allergic rhinitis using rhinomanometry: A randomized controlled trial.
Nakamura Y, Yokoyama Y, Koyama S, Fujiwara K, Nakamori M, Fujii T, Enomoto T, Takeuchi H. Nakamura Y, et al. Asian Pac J Allergy Immunol. 2021 Feb 21. doi: 10.12932/AP-160920-0963. Online ahead of print. Asian Pac J Allergy Immunol. 2021. PMID: 33638625 Free article.
BACKGROUND: A fexofenadine/pseudoephedrine combination tablet (F/P) is an optimal product for nasal obstruction. It contains fexofenadine hydrochloride, a histamine H1-receptor antagonist for sneezing and rhinorrhea and pseudoephedrine hydrochloride, a …
BACKGROUND: A fexofenadine/pseudoephedrine combination tablet (F/P) is an optimal product for nasal obstruction. It contains …
33 results